COMPANY PRODUCT TYPE THERAPEUTIC AREA INDICATION PHASE STUDIES LOCATION PRODUCT
ADL Bionatur Solutions Splittera for diagnostics Diagnostic Others Splittera for diagnostics enhances the sensibility and accuracy of diagnostic systems. Already licensed in non-exclusivity for IVD systems to Biokit 5RTM Splittera for diagnostics
Therapeutic area: Others
ADM BIOPOLIS Microbiome Analysis Diagnostic Autoimmune & Inflammation
Dermatology
Digestive System
Metabolic / Endocrinology
Women´s health
Various 5RTM Worldwide Microbiome Analysis
Therapeutic area: Autoimmune & Inflammation
Dermatology
Digestive System
Metabolic / Endocrinology
Women´s health
ADmit Therapeutics ADmit Test Biomarkers / Diagnostic Central Nervous System Alzheimer's disease in prodromic stage (Mild Cognitive Impairment) 3CV Spain, Australia ADmit Test
Therapeutic area: Central Nervous System
ADNTRO Biomarkers identification Biomarkers Central Nervous System GWAS to identify genetic variants associated with Alzheimer. 1R+D Spain Biomarkers identification
Therapeutic area: Central Nervous System
ADNTRO ADNTRO kit Others Others Polygenic risk scores (PRSs) for complex diseases. A useful tool to support medical diagnosis and for diseases prevention. 5RTM Worldwide ADNTRO kit
Therapeutic area: Others
Agrenvec Recombinant proteins, COVID-19 antigens Biomarkers / Diagnostic Infections COVID-19 antigens for immunoassay 3CV SPAIN Recombinant proteins, COVID-19 antigens
Therapeutic area: Infections
ALGENEX (Alternative Gene Expression S.L.) ASFV diagnostic kit Diagnostic Infections African Swine Fever Virus 5RTM ASFV diagnostic kit
Therapeutic area: Infections
ALGENEX (Alternative Gene Expression S.L.) COVID19 diagnostic Biomarkers / Diagnostic Infections COVID19 diagnostic with several proteins 1R+D COVID19 diagnostic
Therapeutic area: Infections
AMADIX (Advanced marker discovery) PancreaDix Biomarkers / Diagnostic Cancer Innovative non-invasive blood-based test for early detection of pancreatic cancer and preneoplastic lesions 3CV Spain PancreaDix
Therapeutic area: Cancer
AMADIX (Advanced marker discovery) ColoFast Biomarkers / Diagnostic Cancer Innovative blood-based test for colorectal cancer early detection 3CV Spain and Europe ColoFast
Therapeutic area: Cancer
AMADIX (Advanced marker discovery) DiagnoLung Biomarkers / Diagnostic Cancer Innovative non-invasive blood-based test for early detection of lung cancer and as a tool for high risk screening population 3CV Spain DiagnoLung
Therapeutic area: Cancer
APTUS Biotech PrediApt Biomarkers / Diagnostic Cancer PREDIAPT is developing two prognostic applications in response to platinum derivative treatment in lung cancer using MAFG as diagnostic biomarker using (i) a system based on the ELONA technique, using aptamers as a recognition molecule, which will detect 2PreV Spain PrediApt
Therapeutic area: Cancer
APTUS Biotech AptaDetect-HCV Diagnostic Infections Hepatitis C virus (HCV) diagnosis based on aptamers 1R+D Spain AptaDetect-HCV
Therapeutic area: Infections
APTUS Biotech Apta-Leish Diagnostic Infections Leishmaniasis diagnosis based on aptamers 1R+D Spain Apta-Leish
Therapeutic area: Infections
Araclon Biotech ABtest-MASAS Service 40/42 Biomarkers Central Nervous System Alzheimer´s disease diagnostic service in the early stages by mass spectrometry. ISO9001 certified. 5RTM Europe ABtest-MASAS Service 40/42
Therapeutic area: Central Nervous System
Araclon Biotech ABtest-ELISA Service 40 / 42 Biomarkers Central Nervous System Alzheimer´s disease diagnostic service in the early stages. ISO9001 certified. 3CV Worldwide ABtest-ELISA Service 40 / 42
Therapeutic area: Central Nervous System
ATRYS HEALTH Personalized Medicine Biomarkers / Diagnostic Cancer Patient stratification for difuse large b-cell lymphoma therapy 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH mAb for diagnosis and prognosis of brain tumors and lesions Biomarkers / Diagnostic Cancer
Central Nervous System
Glioblastoma, neurodegenerative disease 1R+D Spain mAb for diagnosis and prognosis of brain tumors and lesions
Therapeutic area: Cancer
Central Nervous System
ATRYS HEALTH inmunoterapia Biomarkers Cancer Caracterización inmunológica y molecular en biopsia líquida de pacientes de cáncer de pulmón para inmunoterapia 1R+D inmunoterapia
Therapeutic area: Cancer
ATRYS HEALTH telecardio Diagnostic/Imaging Cardiovascular and circulatory systems Herramientas de Telemedicina para la Detección y Prevención de Enfermedades Cardiovasculares 2PreV telecardio
Therapeutic area: Cardiovascular and circulatory systems
ATRYS HEALTH oncliq Biomarkers / Diagnostic Cancer Desarrollo de una plataforma dinámica de detección rápida de alteraciones moleculares accionables a partir de biopsias líquidas y sólidas de pacientes oncológicos 1R+D oncliq
Therapeutic area: Cancer
ATRYS HEALTH Personalized Medicine Patient monitoring equipment Cancer Expert system for breast and colon cancer patient management 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH surveprost Biomarkers Cancer Desarrollo de firma multiómica para predicción de la agresividad tumoral a partir de biopsia líquida en pacientes de cáncer de próstata. 1R+D colombia surveprost
Therapeutic area: Cancer
ATRYS HEALTH radioproliq Biomarkers Cancer Firma molecular en biopsia líquida para respuesta a radioterapia y recaída temprana en cáncer de próstata 2PreV radioproliq
Therapeutic area: Cancer
ATRYS HEALTH Personalized Medicine Biomarkers Cancer Patient stratification in glioma 3CV Spain Personalized Medicine
Therapeutic area: Cancer
ATRYS HEALTH análisis de imágenes médicas Diagnostic/Imaging Others Inteligencia artificial para el análisis de diferentes imágenes médicas: mamografías, radiografías de torax y radiografías osteo-articulares 2PreV España, Colombia, Perú análisis de imágenes médicas
Therapeutic area: Others
ATRYS HEALTH Home-Care HTA Patient monitoring equipment Others medición, valoración y seguimiento de pacientes con HTA 5RTM Home-Care HTA
Therapeutic area: Others
ATRYS HEALTH home care Diabetes Patient monitoring equipment Metabolic / Endocrinology diabetes 5RTM home care Diabetes
Therapeutic area: Metabolic / Endocrinology
Biocross AD Dementia test Biomarkers / Diagnostic Central Nervous System The AD Dementia test is a multiparametric test that combines the detection and quantification of up to 9 metabolites or proteins in a plasma sample. The input of these measurements into an algorithm provides an accurate diagnosis and classifies the patien 2PreV Europe AD Dementia test
Therapeutic area: Central Nervous System
BIOHOPE Immmunobiogram TRANSPLANT Biomarkers / Diagnostic Kidney and Genitourinary system
Musculoskeletal Disorders
Immunobiogram test builds on the measurement of patient’s in-vitro T-cell-based immune response to individual immunosuppressive drugs following kidney transplantation. The test serves as a an aid to the management of immunosuppressive regimen being the te 4Reg. Spain, Denmark, Germany, Poland, USA Immmunobiogram TRANSPLANT
Therapeutic area: Kidney and Genitourinary system
Musculoskeletal Disorders
BIOHOPE Immunobiogram ARTHRITIS Biomarkers / Diagnostic Autoimmune & Inflammation Rheumatoid Arthritis: immunomodulation, immunosuppresion. IVD under development to help define the best immunosupressant combination possible for a certain patient to control the disease. 3CV Spain Immunobiogram ARTHRITIS
Therapeutic area: Autoimmune & Inflammation
Biokit S.A HemosIL Acustar ADAMTS13 Activity Assay Diagnostic Cardiovascular and circulatory systems Thrombotic thrombocytopenic purpura (TTP) 3CV Spain HemosIL Acustar ADAMTS13 Activity Assay
Therapeutic area: Cardiovascular and circulatory systems
BIOLAN HEALTH OSAXYL 7000 Diagnostic Digestive System Hypolactasia. Lactose intolerance 5RTM Spain OSAXYL 7000
Therapeutic area: Digestive System
BIOLAN HEALTH COVID-19 Antigen Rapid Test Diagnostic Infections SARS-CoV-2 ( COVID-19 Diagnostico) 5RTM Spain COVID-19 Antigen Rapid Test
Therapeutic area: Infections
Biomedica Molecular Medicine SL Bio-miRCC Biomarkers / Diagnostic Cancer Bio-miRCC is a prognostic molecular profile for localized renal cancer patients which allows classify them in two risk groups (high and low risk), avoiding the intermediate risk group provided by the current classification systems. 3CV Spain, England Bio-miRCC
Therapeutic area: Cancer
BTI Biotechnology Institute New BTI Apnia Diagnostic Respiratory and Pulmonary system New Respiratory polygraphy device with 7 channels for the diagnosis of obstructive sleep apnea 5RTM New BTI Apnia
Therapeutic area: Respiratory and Pulmonary system
CIBER Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen Diagnostic Infections Candida auris 2PreV Spain Method for rapid detection of Candida auris and diagnosis of infection caused by this pathogen
Therapeutic area: Infections
CIBER METHOD FOR PREDICTING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS Biomarkers / Diagnostic Autoimmune & Inflammation rheumatoid arthritis 3CV METHOD FOR PREDICTING THE DEVELOPMENT OF RHEUMATOID ARTHRITIS
Therapeutic area: Autoimmune & Inflammation
CIBER PredictivModel to predict the development of type 2 diabetes mellitus using miRNAs Biomarkers / Diagnostic Metabolic / Endocrinology Type 2 diabetes mellitus (T2DM) 1R+D PredictivModel to predict the development of type 2 diabetes mellitus using miRNAs
Therapeutic area: Metabolic / Endocrinology
CIBER Biomarkers and method to predict or predict response to treatment with BRAF and MEK inhibitors (BRAFi + MEKi) and for patient follow-up Biomarkers / Diagnostic Cancer Genetic biomarkers, Cancer 1R+D Biomarkers and method to predict or predict response to treatment with BRAF and MEK inhibitors (BRAFi + MEKi) and for patient follow-up
Therapeutic area: Cancer
CIBER Methods for the measurement of protein C and activated protein C Biomarkers / Diagnostic Autoimmune & Inflammation
Infections
Sepsis or septic shock 2PreV Spain Methods for the measurement of protein C and activated protein C
Therapeutic area: Autoimmune & Inflammation
Infections
CIBER Method for diagnosis, prognosis and monitoring of Alzheimer disease using metabolomic techniques Diagnostic Central Nervous System Alzheimer disease 2PreV Spain Method for diagnosis, prognosis and monitoring of Alzheimer disease using metabolomic techniques
Therapeutic area: Central Nervous System
CIBER SALIVA-BASED DIAGNOSTIC TEST FOR EOSINOPHILIC OESOPHAGITIS Biomarkers Digestive System This invention provides a method to analyse the diagnosis and/or prognosis of Eosinophilic Oesophagitis (EoE), using determination and quantification of certain salivary biomarkers. 1R+D Spain SALIVA-BASED DIAGNOSTIC TEST FOR EOSINOPHILIC OESOPHAGITIS
Therapeutic area: Digestive System
CIBER Method for the prediction and / or prevention of overweight, obesity and / or its complications by means of gene expression analysis Biomarkers / Diagnostic Cardiovascular and circulatory systems
Metabolic / Endocrinology
prediction and / or prevention of overweight, obesity, and / or disorders associated to overweight 2PreV Method for the prediction and / or prevention of overweight, obesity and / or its complications by means of gene expression analysis
Therapeutic area: Cardiovascular and circulatory systems
Metabolic / Endocrinology
CIBER Haptens, antibodies and method to detect pseudomonas aeruginosa infections Diagnostic Infections Pseudomonas aeruginosa 1R+D Spain Haptens, antibodies and method to detect pseudomonas aeruginosa infections
Therapeutic area: Infections
CIBER A NON-INVASIVE METHOD TO SELECT PATIENTS FOR BARIATRIC SURGERY Biomarkers / Diagnostic Metabolic / Endocrinology The technology DiaSuc provides a method for selecting a bariatric surgical procedure for a patient, as well as an informative biomarker for predicting, before bariatric surgery, type 2 diabetes remission after bariatric surgery in a patient suffering from 1R+D Spain A NON-INVASIVE METHOD TO SELECT PATIENTS FOR BARIATRIC SURGERY
Therapeutic area: Metabolic / Endocrinology
CIBER USE OF AN MNK kinase inhibitor for the treatment of Triple-negative breast cancer Biomarkers / Diagnostic Cancer
Women´s health
breast cancer 1R+D USE OF AN MNK kinase inhibitor for the treatment of Triple-negative breast cancer
Therapeutic area: Cancer
Women´s health
CIBER BIOSIGNATURES FOR ULCERATIVE COLITIS Biomarkers Digestive System Biosignature to manage the non-responder corticosteroids patients with personalized approach. 1R+D Spain BIOSIGNATURES FOR ULCERATIVE COLITIS
Therapeutic area: Digestive System
CIBER Method to obtain useful data for the diagnosis, prediction or prognosis of colorectal cancer Biomarkers / Diagnostic Cancer diagnosis, prediction or prognosis of colorectal cancer 1R+D Method to obtain useful data for the diagnosis, prediction or prognosis of colorectal cancer
Therapeutic area: Cancer
CIBER New predictive method for the progression of colorectal cancer Biomarkers Cancer It has been patented a new fetal 'gene signature’ capable to predict the worse evolution of the CRC patients who could suffer a relapse after chemotherapeutic regime or surgery. 2PreV Spain New predictive method for the progression of colorectal cancer
Therapeutic area: Cancer
CIBER Biomarker for non-invasive colorectal cancer screening Biomarkers Cancer Early diagnosis of the disease in precancerous phases of colorectal cancer 1R+D Spain Biomarker for non-invasive colorectal cancer screening
Therapeutic area: Cancer
CIBER METHOD FOR MONITORING OR PREDICTING WHETHER A PATIENT SUFFERING FROM OBESITY IS RESPONDING OR WILL RESPOND TO A VERY-LOW-CALORIE KETOGENIC DIET (VLCKD) Biomarkers / Diagnostic Metabolic / Endocrinology Obesity 2PreV METHOD FOR MONITORING OR PREDICTING WHETHER A PATIENT SUFFERING FROM OBESITY IS RESPONDING OR WILL RESPOND TO A VERY-LOW-CALORIE KETOGENIC DIET (VLCKD)
Therapeutic area: Metabolic / Endocrinology
CIBER IDENTIFICATION OF METABOLOMIC SIGNATURES IN URINE SAMPLES FOR TUBERCULOSIS DIAGNOSIS Biomarkers / Diagnostic Infections
Others
diagnosis of tuberculosis 2PreV IDENTIFICATION OF METABOLOMIC SIGNATURES IN URINE SAMPLES FOR TUBERCULOSIS DIAGNOSIS
Therapeutic area: Infections
Others
CIBER NON-INVASIVE METHOD FOR COLORECTAL CANCER DETECTION Biomarkers Cancer A new non-invasive method (so called miRFec) with better performance for identifying patients with colorectal cancer (CRC) and advanced adenomas (AA). 1R+D Spain NON-INVASIVE METHOD FOR COLORECTAL CANCER DETECTION
Therapeutic area: Cancer
DIOMUNE SL SEPSISpredict Biomarkers / Diagnostic Cardiovascular and circulatory systems
Infections
Heart Infarction 2PreV Spain SEPSISpredict
Therapeutic area: Cardiovascular and circulatory systems
Infections
ENTRECHEM Bacterial biomarker of colon cancer Biomarkers Cancer Colon cancer 2PreV Bacterial biomarker of colon cancer
Therapeutic area: Cancer
ENTRECHEM Microbioma analysis Biomarkers Others Development of biomarkers (Microbioma) 1R+D Microbioma analysis
Therapeutic area: Others
FERRER EPICUP (FAB-115) Diagnostic Cancer Cancer of Unkown Primary 5RTM Europe EPICUP (FAB-115)
Therapeutic area: Cancer
FERRER EPIBREAST (FAB-118) Diagnostic Cancer Breast Cancer 1R+D Europe EPIBREAST (FAB-118)
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-19011 Diagnostic Infections In vitro method for the diagnosis of a Pneumocystis jirovecii infection 1R+D Pneumocystis jirovecii infection FISEVI-19011
Therapeutic area: Infections
FUND. PROGRESO Y SALUD FIBICO Biomarkers / Diagnostic Cancer Cancer 1R+D FIBICO
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-17002 Cephalosporin allergy diagnosis Diagnostic Autoimmune & Inflammation Cephalosporin allergy diagnosis 1R+D FIMABIS-17002 Cephalosporin allergy diagnosis
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-21005 CUIDAVEN Others Others App for the Care of Venous Devices 1R+D FIMABIS-21005 CUIDAVEN
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-20015 HemoPer: APP for the management of antithrombotics in perioperative, emergency and COVID19 context Others Others Covid-19 1R+D FIMABIS-20015 HemoPer: APP for the management of antithrombotics in perioperative, emergency and COVID19 context
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-17007 Diagnosis using DWI Diagnostic Central Nervous System Diagnosis using DWI 1R+D FIMABIS-17007 Diagnosis using DWI
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FISEVI-15004 Portable vest for the application of pulmonary therapy and associated procedure Others Others Portable vest for the application of pulmonary therapy and associated procedure 1R+D FISEVI-15004 Portable vest for the application of pulmonary therapy and associated procedure
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-20034 Lactoperoxidase as a potential diagnostic method for the presence of Parkinson's disease and response to treatment Diagnostic Central Nervous System Parkinson, Lactoperoxidase as a potential diagnostic method for the presence of Parkinson's disease and response to treatment 1R+D FIMABIS-20034 Lactoperoxidase as a potential diagnostic method for the presence of Parkinson's disease and response to treatment
Therapeutic area: Central Nervous System
FUND. PROGRESO Y SALUD FIMABIS-18011 Rheumatoid arthritis Biomarkers Biomarkers Autoimmune & Inflammation Rheumatoid arthritis 1R+D FIMABIS-18011 Rheumatoid arthritis Biomarkers
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FISEVI-20011 FEN-COVID-19 Diagnostic Others Covid-19 1R+D FISEVI-20011 FEN-COVID-19
Therapeutic area: Others
FUND. PROGRESO Y SALUD GENYO-19002 METHOD OF OBTAINING USEFUL DATA TO DIAGNOSE HEREDITARY HEMORRHAGIC TELANGIECTASIA Diagnostic Cardiovascular and circulatory systems Method of obtaining useful data to diagnose hereditary hemorrhagic telangiectasia. 1R+D GENYO-19002 METHOD OF OBTAINING USEFUL DATA TO DIAGNOSE HEREDITARY HEMORRHAGIC TELANGIECTASIA
Therapeutic area: Cardiovascular and circulatory systems
FUND. PROGRESO Y SALUD GENYO-20003 SYSTEM FOR THE SIMULTANEOUS DETECTION OF CHROMOSOME ALTERATIONS THROUGH SEQUENCING, CYTOMETRY AND IMAGE. Diagnostic Others SYSTEM FOR THE SIMULTANEOUS DETECTION OF CHROMOSOME ALTERATIONS THROUGH SEQUENCING, CYTOMETRY AND IMAGE. 1R+D GENYO-20003 SYSTEM FOR THE SIMULTANEOUS DETECTION OF CHROMOSOME ALTERATIONS THROUGH SEQUENCING, CYTOMETRY AND IMAGE.
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIBICO-19012 Use of splicing factors as therapeutic targets in prostate cancer. Diagnostic Cancer Use of splicing factors as therapeutic targets in prostate cancer. 1R+D FIBICO-19012 Use of splicing factors as therapeutic targets in prostate cancer.
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-21007 Predict plus Prevent Others Substance Abuse Mental Health, Predict plus Prevent is a set of calculators to predict the appearance of future episodes of depression, anxiety and / or problems with alcohol 1R+D FIMABIS-21007 Predict plus Prevent
Therapeutic area: Substance Abuse
FUND. PROGRESO Y SALUD GENYO-21001 MyPROSLE: a new system to measure the personalized molecular dysregulated profiles of Systemic Lupus Erythematosus patients Diagnostic Autoimmune & Inflammation MyPROSLE: a new system to measure the personalized molecular dysregulated profiles of Systemic Lupus Erythematosus patients 1R+D GENYO-21001 MyPROSLE: a new system to measure the personalized molecular dysregulated profiles of Systemic Lupus Erythematosus patients
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-16005 Clavulanic acid allergy diagnosis Diagnostic Autoimmune & Inflammation Clavulanic acid allergy diagnosis 1R+D FIMABIS-16005 Clavulanic acid allergy diagnosis
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FISEVI-15028 Mobile application for the monitoring and diagnosis of surgical wound infections on an outpatient basis using an image-based telemedicine system (Scarcheck) Diagnostic Mobile application for the monitoring and diagnosis of surgical wound infections on an outpatient basis using an image-based telemedicine system (Scarcheck) 1R+D FISEVI-15028 Mobile application for the monitoring and diagnosis of surgical wound infections on an outpatient basis using an image-based telemedicine system (Scarcheck)
Therapeutic area:
FUND. PROGRESO Y SALUD FISEVI-18026 CellCount-Master Others SYSTEM AND METHOD OF QUANTIFICATION AND CHARACTERIZATION OF CLUSTERS ASSOCIATED WITH CIRCULATING TUMOR CELLS (CTCs) 1R+D FISEVI-18026 CellCount-Master
Therapeutic area:
FUND. PROGRESO Y SALUD FIMABIS-15003 Biomarkers Metabolic / Endocrinology Diabetes / metabolic diseases 1R+D FIMABIS-15003
Therapeutic area: Metabolic / Endocrinology
FUND. PROGRESO Y SALUD FIMABIS-14005 Breast cancer biomarkers Biomarkers Cancer Breast cancer 2PreV FIMABIS-14005 Breast cancer biomarkers
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FISEVI-20005 Equivalent dose converter between different drugs Others Others Equivalent dose converter between different drugs 1R+D FISEVI-20005 Equivalent dose converter between different drugs
Therapeutic area: Others
FUND. PROGRESO Y SALUD FISEVI-19002 MedicalForms: Clinical Information Modeling Tool Others Others Clinical Information Modeling Tool 1R+D FISEVI-19002 MedicalForms: Clinical Information Modeling Tool
Therapeutic area: Others
FUND. PROGRESO Y SALUD FIMABIS-19016 Testicular cancer Biomarkers Biomarkers Cancer Testicular cancer 1R+D FIMABIS-19016 Testicular cancer Biomarkers
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIBAO-19010, Biomarkers for non-invasive diagnosis of pancreatic ductal adenocarcinoma Biomarkers / Diagnostic Cancer Pancreatic ductal adenocarcinoma 2PreV SPAIN FIBAO-19010, Biomarkers for non-invasive diagnosis of pancreatic ductal adenocarcinoma
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD FIMABIS-20017 Classify pluripatological patients Diagnostic Metabolic / Endocrinology
Others
Classify pluripatological patients 3CV Spain FIMABIS-20017 Classify pluripatological patients
Therapeutic area: Metabolic / Endocrinology
Others
FUND. PROGRESO Y SALUD FIBAO-19006 y 09 Gene therapy with hokD and ldrB genes for cancer treatment Others Cancer Gene Therapy - Cancer 2PreV SPAIN FIBAO-19006 y 09 Gene therapy with hokD and ldrB genes for cancer treatment
Therapeutic area: Cancer
FUND. PROGRESO Y SALUD GENYO-19004 SYSTEMIC AUTOIMMUNE DISEASES DIAGNOSTIC AND PROGNOSTIC METHOD Diagnostic Autoimmune & Inflammation Systemic autoimmune diseases diagnostic and/or prognostic method 1R+D GENYO-19004 SYSTEMIC AUTOIMMUNE DISEASES DIAGNOSTIC AND PROGNOSTIC METHOD
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD GENYO-13001 / FIMABIS-13009 Biomarkers Autoimmune & Inflammation Lupus erythematosus / Allergy 2PreV Europe GENYO-13001 / FIMABIS-13009
Therapeutic area: Autoimmune & Inflammation
FUND. PROGRESO Y SALUD FIMABIS-19013 Classify patients by the answer to anti-PD1 treatment Biomarkers Cancer Classify patients by the answer to anti-PD1 treatment 1R+D FIMABIS-19013 Classify patients by the answer to anti-PD1 treatment
Therapeutic area: Cancer
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) Kit for Diagnosis and Prognosis Biomarkers / Diagnostic Autoimmune & Inflammation
Cardiovascular and circulatory systems
Kidney and Genitourinary system
Chronic Kidney Disease (CKD) / Asthma and Allegy severity / Ischaemic stroke and blood pressure 1R+D Spain Kit for Diagnosis and Prognosis
Therapeutic area: Autoimmune & Inflammation
Cardiovascular and circulatory systems
Kidney and Genitourinary system
FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria) New kit for detection and quantification of Sin a1 (Yellow mustard) Diagnostic Metabolic / Endocrinology Food Allergy 2PreV Spain New kit for detection and quantification of Sin a1 (Yellow mustard)
Therapeutic area: Metabolic / Endocrinology
Fundacion MEDINA Biomarkers Platform Biomarkers / Diagnostic Cancer Lung Colon Breast Pancreas 3CV Spain Biomarkers Platform
Therapeutic area: Cancer
Fundacion MEDINA Metabolomics Biomarkers Identification Platform Biomarkers / Diagnostic Cancer
Infections
Metabolic / Endocrinology
Cancer Infectious Metabolism and Infectious Biomarkers 3CV Spain Metabolomics Biomarkers Identification Platform
Therapeutic area: Cancer
Infections
Metabolic / Endocrinology
Fundacion MEDINA In vitro tests for toxicity, safety, ADME and plasma efficacy Diagnostic/Imaging Others Cytotoxicity, Neurotoxicity, Mitochondrial Toxicity, Cardiotoxicity, ADME tox 5RTM Spain In vitro tests for toxicity, safety, ADME and plasma efficacy
Therapeutic area: Others
GENOMICA NEDXA Diagnostic/Imaging Others
Women´s health
Point of Care instrument/ Lab on a Chip 1R+D Spain NEDXA
Therapeutic area: Others
Women´s health
IIS La Fe Porous material for the detection of Candida albicans and method of diagnosis Diagnostic/Imaging Infections Porous material for the detection of Candida albicans and method of diagnosis 2PreV Spain Porous material for the detection of Candida albicans and method of diagnosis
Therapeutic area: Infections
IIS La Fe Determination of autoantibodies in autoimmune patients Ro/SSA+ Biomarkers / Diagnostic Autoimmune & Inflammation Measurement in a piezoelectric resonator of the relationship between different variables of an interfacial process of molecular recognition antigen-antibody for the screening of samples of autoimmune patients. 1R+D Spain Determination of autoantibodies in autoimmune patients Ro/SSA+
Therapeutic area: Autoimmune & Inflammation
IIS La Fe Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy Biomarkers / Diagnostic Cancer
Cardiovascular and circulatory systems
In vitro method for predicting cardiotoxicity risk in a cancer patient receiving, or susceptible to receive, anthracyclines chemotherapy 5 based on the determination of the expression levels of a combination of 10 circulating miRNAs 2PreV Method for predicting cardiotoxicity risk in cancer patients receiving anthracyclines chemotherapy
Therapeutic area: Cancer
Cardiovascular and circulatory systems
IIS La Fe Method for predicting response to continuous positive air pressure treatment Diagnostic Respiratory and Pulmonary system Predictive method of response to treatment with continuous positive air pressure (CPAP) in patients with sleep apnea and resistant hypertension. 1R+D Spain Method for predicting response to continuous positive air pressure treatment
Therapeutic area: Respiratory and Pulmonary system
IMMUNOSTEP Disposable device for leukocyte separation Diagnostic Autoimmune & Inflammation
Blood and Lymphatic systems
Hematological malignancies 2PreV Spain Disposable device for leukocyte separation
Therapeutic area: Autoimmune & Inflammation
Blood and Lymphatic systems
IMMUNOSTEP Infiltration in CNS Diagnostic Cancer Detection of Leptomeningeal disease 4Reg. Worldwide Infiltration in CNS
Therapeutic area: Cancer
IMMUNOSTEP Hemodilución (Bmplex) Diagnostic Blood and Lymphatic systems Detection of hemodilution in bone marrow samples 3CV Worldwide Hemodilución (Bmplex)
Therapeutic area: Blood and Lymphatic systems
IMMUNOSTEP Anti-SARS-CoV-2 Test Multiantígeno para IgG+IgA+IgM Diagnostic/Imaging Infections Multiantigen IgG+IgA+IgM Assay is a multiplex, microsphere-based, highly sensitive and specific assay that measure the presence or absence of antibodies against four different SARS-CoV-2 antigens simultaneously. 4Reg. EUROPA Anti-SARS-CoV-2 Test Multiantígeno para IgG+IgA+IgM
Therapeutic area: Infections
IMMUNOSTEP ThromboStep Diagnostic Cardiovascular and circulatory systems Autoimmune Thrombocytopenia Diagnosis by flow cytometry 5RTM Europe ThromboStep
Therapeutic area: Cardiovascular and circulatory systems
Integromics Genomics Analysis for Personalized Medicine/Diagnosis Biomarkers / Diagnostic Others Diagnostics and Imaging / Screening 1R+D Genomics Analysis for Personalized Medicine/Diagnosis
Therapeutic area: Others
IRYCIS miRNA 127 agents for use in the treatment of renal fibrosis Biomarkers / Diagnostic Kidney and Genitourinary system A method of prophylactically or therapeutically treating Chronic kidney disease (CKD) or of reducing the risk of CKD disease progression in a patient comprising expressing miR-127 in the renal cells 3CV Spain miRNA 127 agents for use in the treatment of renal fibrosis
Therapeutic area: Kidney and Genitourinary system
IRYCIS New aptamers for diagnosis of COVID19 Biomarkers / Diagnostic Autoimmune & Inflammation
Others
Development of therapeutic aptamers against the SARS-Cov2 spike protein and different highly conserved viral peptides in regions involved in the entry of the virus 1R+D New aptamers for diagnosis of COVID19
Therapeutic area: Autoimmune & Inflammation
Others
IRYCIS Biomarkers to identify IFN-BETA drug responders in patients with multiple sclerosis Biomarkers / Diagnostic Autoimmune & Inflammation
Central Nervous System
New patented method to identify good responders to Interferon beta (INF-beta) therapy in multiple sclerosis before treatment initiation 5RTM Spain Biomarkers to identify IFN-BETA drug responders in patients with multiple sclerosis
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
IRYCIS New biomarkers to predict secundary autoimmunity before the treatment with alemtuzumab in MS Biomarkers Autoimmune & Inflammation
Central Nervous System
New method to determine the probability to develop a secondary autoimmune disease before the treatment with alemtuzumab in patients with Multiple Sclerosis 5RTM Spain New biomarkers to predict secundary autoimmunity before the treatment with alemtuzumab in MS
Therapeutic area: Autoimmune & Inflammation
Central Nervous System
IRYCIS ACE2 determination and prognosis of COVID19 Biomarkers / Diagnostic Autoimmune & Inflammation
Others
Differences in saliva ACE2 activity among infected and non-infected adult and pediatric population exposed to SARS-CoV-2 1R+D ACE2 determination and prognosis of COVID19
Therapeutic area: Autoimmune & Inflammation
Others
IRYCIS New biomarkers to identify good responders to cis-platinum in lug cancer Biomarkers / Diagnostic Cancer New biomarkers based on aptamers technology (target MAFG) to identify good responders to cis-platinum in lug cancer 2PreV New biomarkers to identify good responders to cis-platinum in lug cancer
Therapeutic area: Cancer
IRYCIS Aptamers against MNK1 for the treatment of breast cancer Others Cancer Aptamers against MNK1 for the treatment of breast cancer 2PreV Aptamers against MNK1 for the treatment of breast cancer
Therapeutic area: Cancer
IRYCIS Biomarkers to identify the response to OIT of children allergics to caw milk proteins Biomarkers / Diagnostic Autoimmune & Inflammation
Others
Biomarkers based on IgE profile for determining oral immunotherapy treatment response in children with cow’s milk protein allergy (with F. Hospital CI) 3CV Spain Biomarkers to identify the response to OIT of children allergics to caw milk proteins
Therapeutic area: Autoimmune & Inflammation
Others
IRYCIS Noverl biomarkers of acute kidney injury based on miRNAs Biomarkers / Diagnostic Kidney and Genitourinary system The identified panel of miRNAs can detect acute kidney injury (AKI) development before serum creatinine increases 3CV Spain Noverl biomarkers of acute kidney injury based on miRNAs
Therapeutic area: Kidney and Genitourinary system
Leitat Microbiome profile Biomarkers Cancer
Dental
Dermatology
Digestive System
Metabolic / Endocrinology
microbiome characterization (including 3 biomes: bacteria, fungi and viruses) and its relantionship with health&disease, response to treatments 2PreV Microbiome profile
Therapeutic area: Cancer
Dental
Dermatology
Digestive System
Metabolic / Endocrinology
Leitat Ready-to-use transport kits for xenobiotic interaction studies Others Others To identify xenobiotic interactions for regulatory purposes 5RTM Europe Ready-to-use transport kits for xenobiotic interaction studies
Therapeutic area: Others
Leitat ELISA kit to detect biomarker levels (S100A7) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of several cancers 2PreV Spain ELISA kit to detect biomarker levels (S100A7)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat ELISA kit to detect biomarker levels (S100P) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of Pancreatic cancer, colon cancer, others 2PreV Spain ELISA kit to detect biomarker levels (S100P)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat ELISA kit to detect biomarker levels (S100A4) Biomarkers / Diagnostic Autoimmune & Inflammation
Cancer
Diagnosis and prognosis of Pancreatic cancer, colon cancer, others 2PreV Spain ELISA kit to detect biomarker levels (S100A4)
Therapeutic area: Autoimmune & Inflammation
Cancer
Leitat Tailored-made formulations with nanoencapsulated active compounds Others Autoimmune & Inflammation
Dermatology
Atopic dermatitis, psoriasis 1R+D Spain Tailored-made formulations with nanoencapsulated active compounds
Therapeutic area: Autoimmune & Inflammation
Dermatology
Leitat Metabolic profile Biomarkers Infections Helicobacter pylori infection, oxidative stress 1R+D Spain Metabolic profile
Therapeutic area: Infections
Leitat In vitro cellular model for diagnosis Biomarkers Infections Helicobacter pylori virulence 1R+D Spain In vitro cellular model for diagnosis
Therapeutic area: Infections
Leitat COVID Diagnostic Infections Antibodies with several tags and different formats for diagnostic use in COVID 2PreV COVID
Therapeutic area: Infections
Leukos Biotech AML IVD Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
AML 3CV Spain AML IVD
Therapeutic area: Blood and Lymphatic systems
Cancer
Life Length Telomere Analysis Technology (TAT Test) Biomarkers Cancer
Cardiovascular and circulatory systems
Others
Age related diseases, Cancer, Cardiovascular, Degenerative diseases 5RTM Europe, US Telomere Analysis Technology (TAT Test)
Therapeutic area: Cancer
Cardiovascular and circulatory systems
Others
Merck / Sysmex Inostics Liquid Biopsy RAS Biomarker Testing Biomarkers / Diagnostic Cancer
Digestive System
Metastatic colorectal cancer 1R+D Spain Liquid Biopsy RAS Biomarker Testing
Therapeutic area: Cancer
Digestive System
Myriad Genetics myPlan™ Renal Cancer Biomarkers / Diagnostic Cancer Test Prognostics for renal cancer 3CV myPlan™ Renal Cancer
Therapeutic area: Cancer
Myriad Genetics myPlan™ Lung Cancer Diagnostic Cancer Lung Cancer prognostic test based on Cell Cycle Progression Genes 3CV Worldwide myPlan™ Lung Cancer
Therapeutic area: Cancer
Myriad Genetics myChoice™ HRD Biomarkers / Diagnostic Cancer Companion diagnostic test to identify metastatic breast cancer, ovarian and other tumor types that may be sensitive to iPAPR and/or platinum 3CV Worldwide myChoice™ HRD
Therapeutic area: Cancer
Myriad Genetics myPath™ Melanoma Biomarkers / Diagnostic Cancer Genetic profile to test pathogenic status of Melanoma biopsy 3CV Worldwide myPath™ Melanoma
Therapeutic area: Cancer
Myriad Genetics myRisk™ Diagnostic Cancer Test for all hereditary cancer syndromes 4Reg. España myRisk™
Therapeutic area: Cancer
Myriad Genetics Vectra® DA Biomarkers Autoimmune & Inflammation
Musculoskeletal Disorders
Multi-biomarker blood test validated to measure Rheumatoid Arthritis 5RTM Vectra® DA
Therapeutic area: Autoimmune & Inflammation
Musculoskeletal Disorders
Myriad Genetics tumor BRACAnalysis CDx™ Biomarkers / Diagnostic Cancer Companion diagnostic tumor testing for mutations in BRCA1/2 genes indicated for patients with ovarian cancer treated with IPARP 4Reg. España tumor BRACAnalysis CDx™
Therapeutic area: Cancer
Myriad Genetics EndoPredict® Biomarkers / Diagnostic Cancer Breast cancer patients ER postive and HER2 negative 4Reg. España EndoPredict®
Therapeutic area: Cancer
Myriad Genetics Prolaris® Biomarkers Cancer Genetic test for prostate cancer 4Reg. España Prolaris®
Therapeutic area: Cancer
NIMGENETICS ExoNIM Trio Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® basada en la secuenciación de los 19.000 genes del paciente y, sus progenitories. La información genética de los progenitores, permite determinar en las variantes identificadas el patrón de herencia. Esta aproximación facilita la i 5RTM Spain ExoNIM Trio
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS TrisoNIM Excellence Diagnostic Genetic Diseases and Dysmorphic syndromes Test de ADN fetal en sangre materna, mediante secuenciación masiva de última generación (NGS, Next Generation Sequencing) y la aplicación del algoritmo NIFTY®. TrisoNIM® es el primer test de ADN fetal realizado íntegramente en España. TrisoNIM® Excellenc 5RTM Spain TrisoNIM Excellence
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Clínico Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® que se focaliza en el análisis de genes con fenotipo OMIM (Online Mendelian Inheritance in Man (OMIM). La secuencia completa queda almacenada, lo que permite la realización de diferentes análisis de forma secuencial. ExoNIM® Clíni 5RTM Spain ExoNIM Clínico
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS TromboNIM Diagnostic Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
Estudio genético de la trombofilia hereditaria dirigido a la identificación de pacientes con un riesgo incrementado de desarrollar enfermedad tromboembólica. Analiza 24 variantes en 18 Genes asociadas a un incremento en el riesgo trombótico. Incluye genes 5RTM Spain TromboNIM
Therapeutic area: Cardiovascular and circulatory systems
Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Personalizado Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación de ExoNIM® que permite el diseño de un panel de genes adaptados a las necesidades del especialista. Las principales ventajas de esta aproximación son: 1. Posibilidad de ampliación del análisis por aparición de nuevos síntomas, redefinición 5RTM Spain ExoNIM Personalizado
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS KaryoNIM Leukemia Diagnostic Cancer Plataforma genómica diseñada por NIMGenetics para la identificación de biomarcadores en la leucemia linfática crónica (LLC), que combina la tecnología de array CGH y de SNParray. 1. El array CGH ha demostrado ser la tecnología más eficaz en este tipo de 5RTM Spain KaryoNIM Leukemia
Therapeutic area: Cancer
NIMGENETICS ExoNIM Dirigido Diagnostic Genetic Diseases and Dysmorphic syndromes Aproximación al análisis del exoma basada en la selección de genes asociados al fenotipo del paciente. Tras la secuenciación de los 19.000 genes del paciente, se analizan aquellos asociados al cuadro clínico. La secuencia completa queda almacenada, lo que 5RTM Spain ExoNIM Dirigido
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
NIMGENETICS ExoNIM Plus Epilepsia Diagnostic Genetic Diseases and Dysmorphic syndromes Abordaje global para el estudio de las distintas formas clínicas de la epilepsia que analiza 223 genes con relevancia clínica a partir de la secuenciación del exoma completo (ExoNIM®). La secuencia obtenida queda almacenada, lo que permite la aplicación 5RTM Spain ExoNIM Plus Epilepsia
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
OPERON NG Oligogen Biomarkers / Diagnostic Infections Molecular Test for the detection of Neisseria goorrhoeae 5RTM Spain NG Oligogen
Therapeutic area: Infections
OPERON CT/NG/MG Oligogen Diagnostic Infections Molecular test for the simultaneous detection of Chlamydia trachomatis, Nisseria gonorrhoeae, and Mycobacterium genitalis. 5RTM Spain CT/NG/MG Oligogen
Therapeutic area: Infections
OPERON S. PneumoStrip Diagnostic Respiratory and Pulmonary system Molecular test for the serotyping of Streptococcus pneumoniae 4Reg. Spain S. PneumoStrip
Therapeutic area: Respiratory and Pulmonary system
OPERON CT Oligogen Biomarkers / Diagnostic Infections Molecular test for the detection of Chlamydia trachomatis 5RTM Spain CT Oligogen
Therapeutic area: Infections
OPERON MG Oligogen Biomarkers / Diagnostic Infections Test designed for the detection of Mycoplasma genitalium 5RTM Spain MG Oligogen
Therapeutic area: Infections
OWL Metabolomics OWLiverF2+ Biomarkers / Diagnostic Cancer
Dermatology
Digestive System
Metabolic / Endocrinology
Non-alcoholic steatohepatitis + Fibrosis 5RTM Europe & America OWLiverF2+
Therapeutic area: Cancer
Dermatology
Digestive System
Metabolic / Endocrinology
OWL Metabolomics OWLiver Care Biomarkers / Diagnostic Digestive System Non-alcoholic fatty liver disease 5RTM Europe & America OWLiver Care
Therapeutic area: Digestive System
OWL Metabolomics Metabolomics Services Biomarkers / Diagnostic Digestive System
Others
Preclinical and clinical studies 5RTM Europe, America & Asia Metabolomics Services
Therapeutic area: Digestive System
Others
Progenika Biopharma Promonitor - PoC Others Autoimmune & Inflammation Point of Care - Therapeutic drug monitoring 4Reg. Spain Promonitor - PoC
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - ELISA Others Autoimmune & Inflammation Therapeutic drug monitoring 1R+D Spain Promonitor - ELISA
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - ELISA Others Autoimmune & Inflammation Therapeutic drug monitoring 4Reg. Spain Promonitor - ELISA
Therapeutic area: Autoimmune & Inflammation
Progenika Biopharma Promonitor - PoC Others Autoimmune & Inflammation Point of Care - Therapeutic drug monitoring 1R+D Spain Promonitor - PoC
Therapeutic area: Autoimmune & Inflammation
PROMEGA BIOTECH IBÉRICA Microsatellite Instability Analysis CE-IVD Biomarkers / Diagnostic Cancer Characterize MSI Status by a Fluorescent Multiplex PCR-based method with CE/IVD label 5RTM Global Microsatellite Instability Analysis CE-IVD
Therapeutic area: Cancer
PROMEGA BIOTECH IBÉRICA Spectrum Compact CE System Diagnostic Cancer 4-capillary instrument labelled as CE to run MSI fragment analysis for cancer diagnosis 4Reg. Spectrum Compact CE System
Therapeutic area: Cancer
PROMEGA BIOTECH IBÉRICA Lumit SARS-CoV 2 Diagnostic Infections Immunoassay kit to detect SARS-CoV 2 4Reg. Lumit SARS-CoV 2
Therapeutic area: Infections
SECUGEN GENOTYPING Diagnostic/Imaging Ophthalmology and optometry Genetic risk for Age related Macular Degeneration 5RTM Worldwide GENOTYPING
Therapeutic area: Ophthalmology and optometry
SECUGEN Service for the detection and quantification of autoantibodies against CFH and CFI Biomarkers Autoimmune & Inflammation
Genetic Diseases and Dysmorphic syndromes
Complement system related disorders 5RTM Spain Service for the detection and quantification of autoantibodies against CFH and CFI
Therapeutic area: Autoimmune & Inflammation
Genetic Diseases and Dysmorphic syndromes
SECUGEN NEXT GEN SEQUENCING Diagnostic/Imaging Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Kidney and Genitourinary system
Genetic Diagnosis 5RTM Worldwide NEXT GEN SEQUENCING
Therapeutic area: Central Nervous System
Genetic Diseases and Dysmorphic syndromes
Kidney and Genitourinary system
SECUGEN DNA SEQUENCING Diagnostic/Imaging Genetic Diseases and Dysmorphic syndromes Genetic Diagnosis 5RTM Worldwide DNA SEQUENCING
Therapeutic area: Genetic Diseases and Dysmorphic syndromes
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Diagnostic Blood and Lymphatic systems
Cancer
Acute Myeloid Leukaemia 5RTM Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
Acute Lymphocytic Leukaemia 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Blood and Lymphatic systems
Cancer
Chronic Lymphocytic Leukaemia 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Blood and Lymphatic systems
Cancer
Vivia Biotech Personalized Medicine Test in Haematological Malignancies Biomarkers / Diagnostic Cancer Multiple Myeloma 3CV Europe Personalized Medicine Test in Haematological Malignancies
Therapeutic area: Cancer